NSAIDs and Cardiac Risk Concerns (Pharma Mastery Lecture 8)

Duration: 1:07:09

Write A New Comment

0 Comments

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for pain and inflammation, but their impact on cardiovascular health remains a concern. This lecture explores the mechanisms through which NSAIDs influence cardiovascular physiology, including their effects on blood pressure, platelet aggregation, and endothelial function. Key cardiovascular risks associated with NSAID use, such as myocardial infarction, heart failure, and hypertension, will be reviewed.

Learning Objectives.
Understand the mechanisms through which NSAIDs affect cardiovascular physiology.
Identify key cardiovascular risks associated with NSAID use, such as myocardial infarction and heart failure.
Discuss evidence-based strategies for mitigating cardiovascular risks.

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

DrBeen: Online Personalized Medical Education - DrBeen
https://www.drbeen.com/

Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue - PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC5422108/

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis | New England Journal of Medicine
https://www.nejm.org/doi/full/10.1056/NEJM200011233432103

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis | New England Journal of Medicine
https://www.nejm.org/doi/full/10.1056/NEJMoa1611593

Nonsteroidal Anti-Inflammatory Drugs and the Heart | Circulation
https://www.ahajournals.org/doi/10.1161/circulationaha.113.004480

Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S0735109720355728

Learning Objectives.

Understand the mechanisms through which NSAIDs affect cardiovascular physiology.
Identify key cardiovascular risks associated with NSAID use, such as myocardial infarction and heart failure.
Discuss evidence-based strategies for mitigating cardiovascular risks.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty	Disclosures
Dr. Mobeen Syed	Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharma Mastery

Videos in Course
Favourite Videos

1.00 CME

Aspirin (Pharma Mastery Lecture 1)

55:23

Dr. Mobeen Syed

0.75 CME

Aspirin Indications (Pharma Mastery Lecture 2)

45:44

Dr. Mobeen Syed

1.00 CME

Aspirin Side-effects and Clinical Gems (Pharma Mastery Lecture 3)

1:01:26

Dr. Mobeen Syed

0.75 CME

Ibuprofen (Pharma Mastery Lecture 4)

46:54

Dr. Mobeen Syed

0.75 CME

Acetaminophen (Pharma Mastery Lecture 5)

50:07

Dr. Mobeen Syed

0.21 CME

Aspirin and Colorectal Cancer (Pharma Mastery Lecture 6)

12:18

Dr. Mobeen Syed

0.25 CME

Aspirin and Atrial Fibrillation – A Review of Evidence

19:34

Dr. Mobeen Syed

1.00 CME